Zeo ScientifiX and Pluri sign license-for-equity deal, Pluri to own 50%
Pluri will license its 3D cell-expansion manufacturing technology to Zeo and take majority voting control through new preferred stock, with closing targeted for the fourth quarter of 2026.
SEC filing